Division of Gastroenterology

Active Projects: 26

Project Investigator All Organizations Start date End date
The Genetic Basis of Pediatric Cholestasis Laura N. Bull, PhD Division of Gastroenterology
Dysfunctional Immune Development Among Infants Born to Mothers with IBD Uma Mahadevan, MD Division of Gastroenterology
Patients' HBV Knowledge, Attitudes, Barriers to HBV Care and HBV Treatment Mandana Khalili, MD Division of Gastroenterology
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B Mandana Khalili, MD Division of Gastroenterology
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re Mandana Khalili, MD Division of Gastroenterology
A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients Norah A. Terrault, MD Division of Gastroenterology
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Division of Gastroenterology
Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Study Evaluating the Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in HIV+ Subjects with HIV-Associated Enteropathy Ma Somsouk, MD, MAS Division of Gastroenterology
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Division of Gastroenterology
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir with Ribavirin in Cirrhotic Subjects with Genotype 3 Chronic Hepatitis C Infection Norah A. Terrault, MD Division of Gastroenterology
A Phase 2 open-label study in patients with recurrent Genotype 1 hepatitis C post-orthotopic liver transplant to explore the safety and efficacy of Simeprevir and Sofosbuvir with and without Ribavirin Norah A. Terrault, MD Division of Gastroenterology
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 Mandana Khalili, MD Division of Gastroenterology
B3041001: a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of Multistem (Pf-05285401) in Subjects with Moderate to Severe Ulcerative Colitis Jonathan Terdiman, MD Division of Gastroenterology
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Norah A. Terrault, MD Division of Gastroenterology
GS-US-248-0122: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection Mandana Khalili, MD Division of Gastroenterology
Ubiquitin and Psoriasis Averil I. Ma, MD Division of Gastroenterology
Protocol M12-999: Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adult Liver Transplant Recipients with Genotype 1 Hepatitis C Virus (HCV) Infection Norah A. Terrault, MD Division of Gastroenterology
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting Norah A. Terrault, MD Division of Gastroenterology
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies Norah A. Terrault, MD Division of Gastroenterology
A Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients with Chronic Hepatitis C Virus Genotype 1 - 6 Infection (MAGELLAN-2) Norah A. Terrault, MD Division of Gastroenterology
A Phase 1 Open-Label, Dose-Finding Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients with Advanced Solid Tumors Division of Gastroenterology
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion G. Peters, MD Global Health Sciences Faculty Affiliate, Division of Gastroenterology
CC 15957 A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, and Pharmacokinetics of AM0010 in Patients with Advanced Solid Tumors Division of Gastroenterology
INRSA Training Grant in Gastroenterology Averil I. Ma, MD Division of Gastroenterology
Inner City Asthma consortium 3 (ICAC3) Susan Lynch, PhD Division of Gastroenterology
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis Mandana Khalili, MD Division of Gastroenterology

Archived Projects: 54

Project Investigator All Organizations Start date End date
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B Mandana Khalili, MD Division of Gastroenterology
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans Mandana Khalili, MD Division of Gastroenterology
Hcv-Induced Alterations in Glucose Metabolism Mandana Khalili, MD Division of Gastroenterology
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Division of Gastroenterology
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Division of Gastroenterology
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia Susan Lynch, PhD Division of Gastroenterology
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation Susan Lynch, PhD Division of Gastroenterology
Analysis of Urban Aerosols in Major U.S. Cities - Implications for Asthmatic Airways Susan Lynch, PhD Division of Gastroenterology
Hepatitis C: Studies of Immunity and Pathogenesis Kimberly A. Page, PhD, MPH Division of Gastroenterology
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study Mandana Khalili, MD Division of Gastroenterology
Prevention of Emergence of Antibiotic Resistant P. aeruginosa Susan Lynch, PhD Division of Gastroenterology
NKT Cells Recognize and Respond to Microbes at Mucosal Surfaces Susan Lynch, PhD Division of Gastroenterology
AIDS Clinical Trials Group Network (ACTG) Marion G. Peters, MD Global Health Sciences Faculty Affiliate, Division of Gastroenterology
Probiotic Outcomes of Enteric Microbiota Susan Lynch, PhD Division of Gastroenterology
HIV Status and Reproductive Aging Affect Liver Fibrosis in HIV/HCV Infected Women Marion G. Peters, MD Global Health Sciences Faculty Affiliate, Division of Gastroenterology
M13-099: Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis (TURQUOISE-II) Norah A. Terrault, MD Division of Gastroenterology
Defective Adaptive Immune Response and Colorectal Neoplasia in HIV-Infected Individuals Ma Somsouk, MD, MAS Division of Gastroenterology
Resequencing Microarray for Rapid Detection and Antimicrobial Resistance Profiling Susan Lynch, PhD Division of Gastroenterology
Age-Dependent Immune Responses to Hepatitis B: a Mouse Model of Human Disease Jody L. Baron, MD, PhD Division of Gastroenterology
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus Mandana Khalili, MD Division of Gastroenterology
L-Carnitine to Treat Fatigue Associated with Crohn's Disease Uma Mahadevan, MD Division of Gastroenterology
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of GS-7977 and Ribavirin for 24 weeks in Subjects with Recurrent Chronic HCV Post Liver Transplant Norah A. Terrault, MD Division of Gastroenterology
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network: Noninvasive Radiological Diagnosis and Cardiovascular Impact of Nonalcoholic Fatty Liver Disease Norah A. Terrault, MD Division of Gastroenterology
Models for Optimal Liver Transplant Outcomes Norah A. Terrault, MD Division of Gastroenterology
UCSF IBD Fellowship 2013 - 2014 Uma Mahadevan, MD Division of Gastroenterology
BMS-790052 with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 1 Mandana Khalili, MD Division of Gastroenterology
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) Mandana Khalili, MD Division of Gastroenterology
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers Mandana Khalili, MD Division of Gastroenterology
AIDS Clinical Trials Group (ACTG), TSG Committee Chair funding Marion G. Peters, MD Global Health Sciences Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute
Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos Mandana Khalili, MD Division of Gastroenterology
GS-US-337-0123 A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post- Norah A. Terrault, MD Division of Gastroenterology
Role of the Human Microbiome in Inflammatory Bowel Disease amongst Migrant South Asian Populations. Susan Lynch, PhD Division of Gastroenterology
A20 Regulation of Psoriasis Susceptibility. Averil I. Ma, MD Division of Gastroenterology
Racial/Ethnic Differences in Fibrosis Progression in HIV/HCV Co-Infected Women Monika A. Sarkar, MD, MAS Division of Gastroenterology
Ubiquitylation and the Regulation of Immune Homeostasis Averil I. Ma, MD Division of Gastroenterology
HIV, Gut Epithelial Cell Turnover and Mucosal Inflammation, and the Risk of Colorectal Neoplasia Ma Somsouk, MD, MAS Division of Gastroenterology, AIDS Research Institute
GS-US-342-1137: A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis Norah A. Terrault, MD Division of Gastroenterology
Linking ABIN-1 to SLE Susceptibility Averil I. Ma, MD Division of Gastroenterology
Fecal microbial transplantation to reduce HIV-associated inflammation Ma Somsouk, MD, MAS Division of Gastroenterology, AIDS Research Institute
INRSA raining Grant in Gastroenterology Averil I. Ma, MD Division of Gastroenterology
PIANO: Pregnancy in IBD and Neonatal Outcomes: In utero exposure to biologics and increased neonatal infections Uma Mahadevan, MD Division of Gastroenterology
The House Dust Fungal Microbiome - Influences and Effects Susan Lynch, PhD Division of Gastroenterology
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma Susan Lynch, PhD Division of Gastroenterology
A Phase 2b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders Norah A. Terrault, MD Division of Gastroenterology
Reconstitution of the gut microbiome to reduce systemic inflammation during treated HIV infection Ma Somsouk, MD, MAS Division of Gastroenterology
Cognitive load theory in the workplace and implications for health professions education: A critical-realist review of studies among diverse professions Division of Gastroenterology
Sinusitis in Children and the Nasopharyngeal Microbiome Susan Lynch, PhD Division of Gastroenterology
Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults with Thrombocytopenia Associated with Liver Disease Prior to an Elective Procedure Norah A. Terrault, MD Division of Gastroenterology
Sinus Microbiome Restoration Study Susan Lynch, PhD Division of Gastroenterology
A20 Mediated Regulation of Colitis and Spondyloarthritis Averil I. Ma, MD Division of Gastroenterology
Ubiquitylation and the Regulation of Immune Homeostasis Averil I. Ma, MD Division of Gastroenterology
A20 Mediated Regulation of Colitis and Spondyloarthritis Averil I. Ma, MD Division of Gastroenterology
Ubiquitin, Inflammasome, and Colitis Averil I. Ma, MD Division of Gastroenterology
Identifying and Modulating Therapeutic Targets in a Model of Hepatitis B Jody L. Baron, MD, PhD Division of Gastroenterology